Diabetic retinopathy: Early diagnosis and effective treatment
- PMID: 20186318
- PMCID: PMC2828250
- DOI: 10.3238/arztebl.2010.0075
Diabetic retinopathy: Early diagnosis and effective treatment
Abstract
Background: Diabetic retinopathy is a microangiopathy of the retina from which nearly all persons with diabetes eventually suffer. Two of its complications threaten the patient's vision: diabetic macular edema and proliferative diabetic retinopathy.
Methods: Selective literature review, based on national and international guidelines and a literature search from 1981 onward.
Results: Diabetic retinopathy is subdivided into non-proliferative and proliferative retinopathy. Macular edema can arise at any stage of the disease and threatens visual acuity. The main risk factors for the development and progression of diabetic retinopathy are long duration of diabetes and poor control of blood sugar and arterial blood pressure. Laser photocoagulation is an evidence-based treatment for proliferative retinopathy and macular edema. Vitreous surgery is indicated in cases of worsening vision due to a non-clearing vitreous hemorrhage or tractional retinal detachment. The current options for medical treatment involve the intravitreous injection of glucocorticosteroids or of a VEGF antagonist; both of these options are "off label" at present.
Conclusion: Diabetic retinopathy is the leading cause of blindness among persons of working age in the industrialized world. Regular ophthalmological examinations, timely laser therapy depending on the stage of the disease, and close interdisciplinary cooperation are essential to prevent loss of vision.
Figures






Comment in
-
Potentially dangerous treatment.Dtsch Arztebl Int. 2010 Jun;107(25):444; author reply 445. doi: 10.3238/arztebl.2010.0444a. Epub 2010 Jun 25. Dtsch Arztebl Int. 2010. PMID: 20644703 Free PMC article. No abstract available.
-
Rheohemapheresis may be successful.Dtsch Arztebl Int. 2010 Jun;107(25):444-5; author reply 445. doi: 10.3238/arztebl.2010.0444c. Epub 2010 Jun 25. Dtsch Arztebl Int. 2010. PMID: 20644704 Free PMC article. No abstract available.
-
Ultraviolet Irradiation.Dtsch Arztebl Int. 2010 Jun;107(25):444; author reply 445. doi: 10.3238/arztebl.2010.0444b. Epub 2010 Jun 25. Dtsch Arztebl Int. 2010. PMID: 20644705 Free PMC article. No abstract available.
Similar articles
-
Screening for and managing diabetic retinopathy: current approaches.Am J Health Syst Pharm. 2007 Sep 1;64(17 Suppl 12):S8-14. doi: 10.2146/ajhp070331. Am J Health Syst Pharm. 2007. PMID: 17720893 Review.
-
Diabetic retinopathy.Clin Cornerstone. 2003;5(2):12-21. doi: 10.1016/s1098-3597(03)90015-9. Clin Cornerstone. 2003. PMID: 12800477 Review.
-
Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.Acta Ophthalmol Scand Suppl. 1997;(223):1-76. Acta Ophthalmol Scand Suppl. 1997. PMID: 9559048
-
Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.Ophthalmology. 2017 Apr;124(4):431-439. doi: 10.1016/j.ophtha.2016.12.005. Epub 2017 Feb 1. Ophthalmology. 2017. PMID: 28161147 Free PMC article. Clinical Trial.
-
[Guidelines of clinical practice of the SERV (Spanish Retina and Vitreous Society): management of ocular complications of diabetes. Diabetic retinopathy and macular oedema].Arch Soc Esp Oftalmol. 2009 Sep;84(9):429-50. doi: 10.4321/s0365-66912009000900003. Arch Soc Esp Oftalmol. 2009. PMID: 19809923 Spanish.
Cited by
-
Advances and Perspectives in Relation to the Molecular Basis of Diabetic Retinopathy-A Review.Biomedicines. 2023 Nov 1;11(11):2951. doi: 10.3390/biomedicines11112951. Biomedicines. 2023. PMID: 38001952 Free PMC article. Review.
-
Effect of intravitreal injection of ranibizumab on retinal ganglion cells and microvessels in the early stage of diabetic retinopathy in rats with streptozotocin-induced diabetes.Exp Ther Med. 2017 Jun;13(6):3360-3368. doi: 10.3892/etm.2017.4431. Epub 2017 May 5. Exp Ther Med. 2017. PMID: 28587414 Free PMC article.
-
The comparative effects of oral Chinese patent medicines in non-proliferative diabetic retinopathy: A Bayesian network meta-analysis of randomized controlled trials.Front Endocrinol (Lausanne). 2023 Apr 3;14:1144290. doi: 10.3389/fendo.2023.1144290. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37077355 Free PMC article.
-
Efficacy of Faricimab in the Treatment of Diabetic Macular Edema and Faricimab-Related Changes in OCT and OCT Angiography.Pharmaceutics. 2025 Jun 30;17(7):858. doi: 10.3390/pharmaceutics17070858. Pharmaceutics. 2025. PMID: 40733068 Free PMC article.
-
Assessment for the Correlation Between Diabetic Retinopathy and Metabolic Syndrome: A Cross-Sectional Study.Diabetes Metab Syndr Obes. 2021 Apr 22;14:1773-1781. doi: 10.2147/DMSO.S265214. eCollection 2021. Diabetes Metab Syndr Obes. 2021. PMID: 33911890 Free PMC article.
References
-
- Hörle S, Grüner F, Kroll P. Epidemiologie diabetischer Erblindungen - eine Übersicht. Klin Monatsbl Augenheilkd. 2002;219(11):777–784. - PubMed
-
- Hamilton AMP, Ulbig MW, Polkinghome P. Management of diabetic retinopathy. London: BMJ Publishing Group; 1996.
-
- Jonas JB. Intravitreal Triamcinolone acetonide for diabetic retinopathy. Dev Ophthalmol. 2007;39:96–110. - PubMed
-
- Early Treatment Diabetic Retinopathy Study Research Group. Early treatment diabetic retinopathy study. Ophthalmology. 1991;98(Suppl 5):739–840. - PubMed
-
- Haritoglou C, Gerss J, Sauerland C, Kampik A, Ulbig MW. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2009;373:1364–1371. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical